Effectiveness of Prophylactic Bolus Ephedrine Versus Norepinephrine for Management of Postspinal Hypotension during Elective Caesarean Section in Resource Limited Setting: A Prospective Cohort Study.

IF 1.6 Q2 ANESTHESIOLOGY
Anesthesiology Research and Practice Pub Date : 2022-10-03 eCollection Date: 2022-01-01 DOI:10.1155/2022/7170301
Mitiku Desalegn, Tewoderos Shitemaw, Habtamu Tamrat
{"title":"Effectiveness of Prophylactic Bolus Ephedrine Versus Norepinephrine for Management of Postspinal Hypotension during Elective Caesarean Section in Resource Limited Setting: A Prospective Cohort Study.","authors":"Mitiku Desalegn,&nbsp;Tewoderos Shitemaw,&nbsp;Habtamu Tamrat","doi":"10.1155/2022/7170301","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Spinal anaesthesia for caesarean section is the preferred technique since it provides better maternal safety and neonatal outcome compared to general anaesthesia. Hypotension is the most common complication after spinal anaesthesia. The study aims to determine the effectiveness of a prophylactic bolus dose of norepinephrine and ephedrine on the management of postspinal hypotension during caesarean section.</p><p><strong>Method: </strong>An institutional-based prospective cohort study was conducted on 84 pregnant women undergoing elective caesarean section. Based on the responsible anaesthetist's postspinal hypotension management plan, patients were divided into two groups. Those patients who received ephedrine are grouped into the ephedrine (EPH, <i>n</i> = 42) group, and patients who received norepinephrine are grouped under the norepinephrine group (NE, <i>n</i> = 42) by data collectors. After aseptic technique, spinal anaesthesia was administered with 0.5% (3 ml) bupivacaine using a 23G spinal needle. During spinal anaesthesia, a prophylactic bolus dose of 10 mg (2 ml) EPH or 16 g (2 ml) NE was given based on management plan of the shift anaesthetist. Mean arterial pressure (MAP), the heart rate (HR), number of boluses of vasopressor used, incidence of nausea and vomiting, and the Apgar score of babies at 1 and 5 min between the groups were recorded.</p><p><strong>Results: </strong>The norepinephrine group had a statistically significant higher MAP compared to the ephedrine group in the first 10 and 15 min (<i>p</i> < 0.05) of the study period. Thereafter, there was no statistically significant difference in MAP between the groups until the end of the study period (<i>p</i> > 0.05). The ephedrine group had a statistically significant higher heart rate throughout the procedure compared to the norepinephrine group (<i>p</i> < 0.05). The norepinephrine group required a lower bolus number of vasopressors compared to the ephedrine group to maintain blood pressure. The Apgar scores of all babies at 1 and 5 min were above seven. Significant differences regarding maternal complications (nausea and vomiting) between the groups were not detected (nausea, <i>p</i>=0.21 and vomiting, <i>p</i>=0.092).</p><p><strong>Conclusion: </strong>Norepinephrine can be used instead of ephedrine to keep a pregnant mother's blood pressure stable during a caesarean section under spinal anaesthesia without causing harm to the mother or baby. Trial registration. ClinicalTrials.gov Identifier: NCT05522088 (Date of registration: 30/08/22).</p>","PeriodicalId":7834,"journal":{"name":"Anesthesiology Research and Practice","volume":" ","pages":"7170301"},"PeriodicalIF":1.6000,"publicationDate":"2022-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550498/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anesthesiology Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/7170301","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Spinal anaesthesia for caesarean section is the preferred technique since it provides better maternal safety and neonatal outcome compared to general anaesthesia. Hypotension is the most common complication after spinal anaesthesia. The study aims to determine the effectiveness of a prophylactic bolus dose of norepinephrine and ephedrine on the management of postspinal hypotension during caesarean section.

Method: An institutional-based prospective cohort study was conducted on 84 pregnant women undergoing elective caesarean section. Based on the responsible anaesthetist's postspinal hypotension management plan, patients were divided into two groups. Those patients who received ephedrine are grouped into the ephedrine (EPH, n = 42) group, and patients who received norepinephrine are grouped under the norepinephrine group (NE, n = 42) by data collectors. After aseptic technique, spinal anaesthesia was administered with 0.5% (3 ml) bupivacaine using a 23G spinal needle. During spinal anaesthesia, a prophylactic bolus dose of 10 mg (2 ml) EPH or 16 g (2 ml) NE was given based on management plan of the shift anaesthetist. Mean arterial pressure (MAP), the heart rate (HR), number of boluses of vasopressor used, incidence of nausea and vomiting, and the Apgar score of babies at 1 and 5 min between the groups were recorded.

Results: The norepinephrine group had a statistically significant higher MAP compared to the ephedrine group in the first 10 and 15 min (p < 0.05) of the study period. Thereafter, there was no statistically significant difference in MAP between the groups until the end of the study period (p > 0.05). The ephedrine group had a statistically significant higher heart rate throughout the procedure compared to the norepinephrine group (p < 0.05). The norepinephrine group required a lower bolus number of vasopressors compared to the ephedrine group to maintain blood pressure. The Apgar scores of all babies at 1 and 5 min were above seven. Significant differences regarding maternal complications (nausea and vomiting) between the groups were not detected (nausea, p=0.21 and vomiting, p=0.092).

Conclusion: Norepinephrine can be used instead of ephedrine to keep a pregnant mother's blood pressure stable during a caesarean section under spinal anaesthesia without causing harm to the mother or baby. Trial registration. ClinicalTrials.gov Identifier: NCT05522088 (Date of registration: 30/08/22).

Abstract Image

Abstract Image

Abstract Image

在资源有限的情况下,预防性注射麻黄碱与去甲肾上腺素对选择性剖宫产术中脊柱后低血压的治疗效果:一项前瞻性队列研究。
背景:与全身麻醉相比,脊髓麻醉在剖宫产术中提供了更好的产妇安全性和新生儿预后,因此是首选技术。低血压是脊髓麻醉后最常见的并发症。本研究旨在确定预防性大剂量去甲肾上腺素和麻黄碱对剖宫产术中脊柱后低血压的治疗效果。方法:对84例择期剖宫产孕妇进行前瞻性队列研究。根据麻醉医师的脊髓后低血压处理方案,将患者分为两组。数据采集人员将接受麻黄素治疗的患者分为麻黄素组(EPH, n = 42),接受去甲肾上腺素治疗的患者分为去甲肾上腺素组(NE, n = 42)。无菌技术后,用23G脊髓针给予0.5% (3ml)布比卡因脊髓麻醉。在脊髓麻醉期间,根据值班麻醉师的管理计划,给予10 mg (2ml) EPH或16 g (2ml) NE的预防性大剂量。记录两组婴儿在1 min和5 min时的平均动脉压(MAP)、心率(HR)、血管加压剂用量、恶心呕吐发生率及Apgar评分。结果:与麻黄碱组相比,去甲肾上腺素组在研究期前10、15 min的MAP增高有统计学意义(p < 0.05)。此后,至研究结束,两组间MAP差异无统计学意义(p > 0.05)。与去甲肾上腺素组相比,麻黄素组在整个手术过程中的心率有统计学意义(p < 0.05)。与麻黄碱组相比,去甲肾上腺素组需要更少的血管加压剂来维持血压。所有婴儿在1分钟和5分钟时的阿普加评分都在7分以上。产妇并发症(恶心和呕吐)组间无显著差异(恶心,p=0.21,呕吐,p=0.092)。结论:去甲肾上腺素可替代麻黄素,在脊髓麻醉下剖宫产时保持孕妇血压稳定,对母婴无危害。试验注册。ClinicalTrials.gov标识符:NCT05522088(注册日期:30/08/22)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.10
自引率
0.00%
发文量
29
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信